Cancer

Papers
(The H4-Index of Cancer is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Issue Information1548
Sharp rise in esophageal cancer and Barrett esophagus seen in middle‐aged people328
Issue Information229
Let's ask the patient: Self‐reported quality‐of‐life measures help to predict kidney cancer mortality183
The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries136
Reply to “Empathic communication: The premise of inclusive care for historically excluded populations”135
Children and adolescents with hematologic cancers deserve better end‐of‐life care118
Stopping immunotherapy after 2 years is practical in patients with advanced non–small cell lung cancer117
The critical need to implement and utilize patient‐reported measures of function in cancer care delivery107
106
MRI is more accurate than a PSMA PET/CT scan for prostate cancer diagnosis104
Understanding risk factors for cancer: What's new and how can it help reduce the cancer burden?98
The economics of advanced and unresectable hepatocellular carcinoma89
Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia87
Potential of circulating tumor DNA to refine immunotherapy75
Multicenter study of pediatric Epstein‐Barr virus–negative monomorphic post solid organ transplant lymphoproliferative disorders73
Childhood cancer mortality trends in the Americas and Australasia: An update to 201768
Updated American Cancer Society lung cancer screening guidelines67
Epistemic equity in oncology: Opportunities to leverage patient‐centric implementation in clinical trial design57
Issue Information57
What enhanced recovery means for patients with cancer undergoing surgery55
Family characteristics and childcare patterns associated with early social functioning in cancer‐bereaved parents53
Cutaneous β‐HPV may predict cutaneous squamous cell carcinoma53
53
Issue Information50
Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer50
Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas50
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced non–small cell lung cancer48
New standard of care for multiple myeloma?48
48
Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?48
Erratum to “Chimeric antigen receptor–based immunotherapy in breast cancer: Recent progress in China”48
Top advances of the year: Cervical cancer47
Characteristics of clinical trials of new oncology drugs approved in China47
Erratum to “Incorporation of alemtuzumab into frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study”46
Erratum to “Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation”46
Exemptions to state laws regulating opioid prescribing for patients with cancer‐related pain: A summary46
Effect of smoking reduction, cessation, and resumption on cancer risk: A nationwide cohort study43
Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial43
Reply to “Enhancing the role of social work in managing cancer risks among LGBTQ+ populations” and “The urgency of systematically acquiring sexual orientation and gender identity data (SOGI) to ensure43
New test for detecting cervical adenocarcinoma43
Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana43
International perspectives on the development, application, and evaluation of a multicancer early detection strategy43
0.99740481376648